Endocrinology Information Center
Intensive blood pressure therapy is associated with a significantly lower risk for serious cardiovascular events in the adults with diabetes.
Racial/ethnic differences seen in the association of aldosterone with incident type 2 diabetes.
The USPSTF recommends that clinicians refer adults with a body mass index of 30 or higher to intensive, multicompetent behavioral interventions.
ACP responds to criticism from the ADA, the Endocrine Society, the AACE, and the AADE of guidance that clinicians should aim to achieve an HbA1c level between 7% and 8% in most people with type 2 diabetes.
The utility and effectiveness of wearable fitness devices are discussed in a clinician's opinion piece.
Obesity is a chronic, progressive disease, and continued communication on prevention and treatment is paramount to reversing the status quo.
The early diagnosis and management of prediabetes will have a significant impact on patient outcomes and healthcare spending.
Divergent recommendations in guidelines from the USPSTF and the ATA/AACE contribute to the controversy surrounding whether to test and treat for subclinical hypothyroidism.
With the holiday season in full swing, clinicians and patients alike face difficulties in staying healthy and happy. Click through ...
Alpha-lipoic acid, 600mg daily, is an effective treatment option for patients with diabetic peripheral neuropathy.
Patients should be encouraged to incorporate daily exercise into their treatment regimen.
When symptoms of thyroid disease are present, clinicians should check thyroid antibodies even if thyroid function is normal.
SGLT2 receptor blockers are only approved for type 2 diabetes.
An older male patient started antidepressants for neuropathy pain but developed hyponatremia as a result.
An obese patient with chronic hepatitis C, diabetes, advanced cirrhosis, and fatty pancreas presents with chronic right-to-middle upper-abdomen pain.